The endothelins (ETs) are regulatory peptides, distributed in many org
an systems and with potent physiological effects. ETs represent the mo
st powerful vasoconstrictive substances known today. They also act as
growth factors and seem to be involved in fetal development. Much data
support a pathophysiological role for ETs, especially in diseases of
the vascular system, such as hypertension, preeclampsia, ischemic hear
t disease, subarachnoidal haemorrhage, and cerebral ischemia. The deve
lopment of drugs affecting ET-receptors and the biosynthesis of ETs pr
esently attract great interest for the establishment of new treatments
of diseases in which ETs are involved. Hopefully, the elaboration of
more specific ET-receptor ligands will fulfill some of these expectati
ons.